SCHEMBL8099609

SCHEMBL8099609

CC(C)(C)OC(=O)N1CCOCC1N

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
RECQL P46063 1/20 0.46
HSD17B10 Q99714 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
ATM Q13315 2/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
HPGD P15428 1/20 0.35
PIK3R1 P27986 2/20 0.35
PIK3CA P42336 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1926306 0.88 USP2 (0.46) USP2SMN1; SMN2RECQLCA12CA1
SCHEMBL12021701 0.85 USP2 (0.53) USP2SMN1; SMN2RECQLHSD17B10CA12
SCHEMBL12021512 0.85 USP2 (0.53) USP2SMN1; SMN2RECQLHSD17B10CA12
SCHEMBL315706 0.85 USP2 (0.53) USP2SMN1; SMN2RECQLHSD17B10CA12
SCHEMBL925405 0.82 USP2 (0.53) USP2SMN1; SMN2RECQLHSD17B10ATM
SCHEMBL16604806 0.81 SMN1; SMN2 (0.49) USP2SMN1; SMN2RECQLHSD17B10CA12
SCHEMBL16604796 0.81 SMN1; SMN2 (0.49) USP2SMN1; SMN2RECQLHSD17B10CA12
SCHEMBL3511572 0.81 SMN1; SMN2 (0.49) USP2SMN1; SMN2RECQLHSD17B10CA12
SCHEMBL18684984 0.81 USP2 (0.49) USP2SMN1; SMN2RECQLHSD17B10ATM
SCHEMBL315705 0.81 USP2 (0.51) USP2SMN1; SMN2RECQLHSD17B10CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed